Attached files

file filename
EX-99.1 - TIENS BIOTECH GROUP USA INCv194684_ex99-1.htm
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  August 19, 2010
 
 
TIENS BIOTECH GROUP (USA), INC.
(Exact name of registrant as specified in its charter)
 
Delaware 
 
001-32477
 
75-2926439
(State or other jurisdiction of incorporation)
 
(Commission File Number) 
 
(I.R.S. Employer Identification Number)
 
No. 6, Yuanquan Road, Wuqing New-Tech Industrial Park, Tianjin, China 301700
(Address of principal executive offices)
 
Registrant's telephone number, including area code: (86) 22-8213-7658
 
Not applicable
(Former name or former address, if changed since last report.)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting materials pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
 
On August 19, 2010, Tiens Biotech Group (USA), Inc. (the “Company”) issued a press release reporting the Company’s financial results for the fiscal quarter ended June 30, 2010.  The full text of the press release is set forth in Exhibit 99.1 attached hereto.
 
 
Item 9.01  Financial Statements and Exhibits.
 
(d) 
Exhibits.
 
Exhibit Number
Description
 
99.1
Press release, dated August 19, 2010.
 
 
2

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
  TIENS BIOTECH GROUP (USA), INC.  
     
       
Date: August 19, 2010
By:
/s/ Jinyuan Li  
    Name:    Jinyuan Li  
    Title:      Chief Executive Officer  
       
 
 
3

 
 
Exhibits

Exhibit Number
 
Description
     
99.1
 
Press release, dated August 19, 2010.
 
 
4